Last updated: 17 July 2019 at 8:11am EST

David Martin Net Worth




The estimated Net Worth of David Martin is at least $16.9 Million dollars as of 8 October 2015. David Martin owns over 19,000 units of Cardiovascular Systems stock worth over $9,591,140 and over the last 16 years David sold CSII stock worth over $7,281,624.

David Martin CSII stock SEC Form 4 insiders trading

David has made over 40 trades of the Cardiovascular Systems stock since 2011, according to the Form 4 filled with the SEC. Most recently David exercised 19,000 units of CSII stock worth $166,250 on 8 October 2015.

The largest trade David's ever made was exercising 154,080 units of Cardiovascular Systems stock on 22 October 2013 worth over $1,360,526. On average, David trades about 15,965 units every 30 days since 2009. As of 8 October 2015 David still owns at least 479,557 units of Cardiovascular Systems stock.

You can see the complete history of David Martin stock trades at the bottom of the page.



What's David Martin's mailing address?

David's mailing address filed with the SEC is 1225 OLD HIGHWAY 8 NW, , ST. PAUL, MN, 55112.

Insiders trading at Cardiovascular Systems

Over the last 16 years, insiders at Cardiovascular Systems have traded over $72,999,461 worth of Cardiovascular Systems stock and bought 949,532 units worth $8,687,068 . The most active insiders traders include Capital Management Lp Camber, Augustine Lawlor, and Capital Ltdmaverick Capital.... On average, Cardiovascular Systems executives and independent directors trade stock every 14 days with the average trade being worth of $338,920. The most recent stock trade was executed by Martha Goldberg Aronson on 15 August 2022, trading 2,411 units of CSII stock currently worth $48,220.



What does Cardiovascular Systems do?

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease. The company's orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.



What does Cardiovascular Systems's logo look like?

Cardiovascular Systems Inc. logo

Complete history of David Martin stock trades at Cardiovascular Systems

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
8 Oct 2015 David Martin
President and CEO
Option 19,000 $8.75 $166,250
8 Oct 2015
479,557
1 Sep 2015 David Martin
President and CEO
Sale 19,646 $23.81 $467,771
1 Sep 2015
458,818
17 Aug 2015 David Martin
President and CEO
Sale 17,688 $23.99 $424,335
17 Aug 2015
499,160
25 Feb 2015 David Martin
President and CEO
Sale 22,800 $37.02 $844,056
25 Feb 2015
369,689
11 Feb 2015 David Martin
President and CEO
Sale 1,000 $36.55 $36,550
11 Feb 2015
371,689
6 Feb 2015 David Martin
President and CEO
Sale 7,500 $35.85 $268,875
6 Feb 2015
372,689
4 Feb 2015 David Martin
President and CEO
Sale 4,500 $34.96 $157,320
4 Feb 2015
380,189
3 Sep 2014 David Martin
President and CEO
Sale 10,248 $28.85 $295,655
3 Sep 2014
384,689
21 Aug 2014 David Martin
President and CEO
Sale 13,957 $29.03 $405,172
21 Aug 2014
394,937
18 Aug 2014 David Martin
President and CEO
Sale 11,754 $29.28 $344,157
18 Aug 2014
408,894
16 Jul 2014 David Martin
President and CEO
Sale 10,703 $28.83 $308,567
16 Jul 2014
343,349
20 Feb 2014 David Martin
President and CEO
Option 29,200 $8.83 $257,836
20 Feb 2014
382,354
30 Jan 2014 David Martin
President and CEO
Option 50,000 $8.83 $441,500
30 Jan 2014
404,052
21 Nov 2013 David Martin
President and CEO
Option 95,900 $8.83 $846,797
21 Nov 2013
449,952
1 Nov 2013 David Martin
President and CEO
Option 4,100 $8.83 $36,203
1 Nov 2013
358,152
22 Oct 2013 David Martin
President and CEO
Option 154,080 $8.83 $1,360,526
22 Oct 2013
404,052
14 Oct 2013 David Martin
President and CEO
Option 21,170 $8.83 $186,931
14 Oct 2013
375,222
19 Sep 2013 David Martin
President and CEO
Sale 6,702 $20.24 $135,648
19 Sep 2013
354,052
17 Sep 2013 David Martin
President and CEO
Sale 8,030 $20.94 $168,148
17 Sep 2013
360,754
28 Aug 2013 David Martin
President and CEO
Sale 21,552 $20.64 $444,833
28 Aug 2013
297,649
23 Aug 2013 David Martin
President and CEO
Sale 27,229 $21.07 $573,715
23 Aug 2013
319,201
2 Aug 2013 David Martin
President and CEO
Option 38,820 $8.83 $342,781
2 Aug 2013
346,430
30 Jul 2013 David Martin
President and CEO
Sale 11,094 $19.69 $218,441
30 Jul 2013
307,610
3 Jun 2013 David Martin
President and CEO
Sale 10,000 $21.34 $213,400
3 Jun 2013
311,881
30 May 2013 David Martin
President and CEO
Option 53,530 $9.34 $499,970
30 May 2013
326,900
13 Mar 2013 David Martin
President and CEO
Sale 10,000 $20.34 $203,400
13 Mar 2013
293,450
11 Mar 2013 David Martin
President and CEO
Sale 26,502 $18.24 $483,396
11 Mar 2013
303,450
19 Feb 2013 David Martin
President and CEO
Sale 8,637 $16.15 $139,488
19 Feb 2013
329,952
31 Jan 2013 David Martin
President and CEO
Sale 10,500 $15.20 $159,600
31 Jan 2013
338,589
11 Jan 2013 David Martin
President and CEO
Sale 1,079 $14.90 $16,077
11 Jan 2013
349,089
28 Nov 2012 David Martin
President and CEO
Sale 900 $11.50 $10,350
28 Nov 2012
1,100
27 Nov 2012 David Martin
President and CEO
Sale 3,600 $11.61 $41,796
27 Nov 2012
350,168
31 Aug 2012 David Martin
President and CEO
Sale 1,100 $9.07 $9,977
31 Aug 2012
353,768
24 Aug 2012 David Martin
President and CEO
Sale 862 $9.03 $7,784
24 Aug 2012
359,068
21 Aug 2012 David Martin
President and CEO
Sale 10,510 $9.07 $95,326
21 Aug 2012
359,930
16 Aug 2012 David Martin
President and CEO
Sale 12,582 $8.82 $110,973
16 Aug 2012
370,440
13 Aug 2012 David Martin
President and CEO
Sale 11,528 $8.87 $102,253
13 Aug 2012
383,022
27 Feb 2012 David Martin
President and CEO
Sale 9,000 $9.30 $83,700
27 Feb 2012
285,380
16 Aug 2011 David Martin
President and CEO
Sale 18,854 $13.69 $258,111
16 Aug 2011
295,980
8 Aug 2011 David Martin
President and CEO
Sale 18,355 $13.77 $252,748
8 Aug 2011
314,834


Cardiovascular Systems executives and stock owners

Cardiovascular Systems executives and other stock owners filed with the SEC include: